Regulatory T cells for tolerance therapy: Revisiting the concept

Critical Reviews in Immunology

Volumn 31, Issue 3, 2011, Pages 189-207

  LeGuern, Christian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell therapy; Deletion; Immune regulation; Suppression; Thymus; Tolerance; Treg

Indexed keywords

AUTOANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ALLOGRAFT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELL THERAPY; CLINICAL TRIAL (TOPIC); EFFECTOR CELL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYMUS; TRANSPLANTATION TOLERANCE;

EID: 79959309401     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v31.i3.20     Document Type: Article

References (163)

1. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev. 2003 Mar;3(3):199-210.
2. Long E, Wood KJ. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation. 2009 Nov 15;88(9):1050-6.
3. Wieckiewicz J, Goto R, Wood KJ. T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol. 2010 Oct;22(5):662-8.
4. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008 May 30;133(5):775-87.
5. Waldmann H, Chen TC, Graca L, Adams E, Daley S, Cob-bold S, Fairchild PJ. Regulatory T cells in transplantation. Semin Immunol. 2006 Apr;18(2):111-9.
6. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol. 2010 Oct;6(10):577-83.
7. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331-60.
8. Matzinger P. Why positive selection? Immunol Rev. 1993;135:81-117.
9. Berg LJ, Pullen AM, Fazekas de St.Groth B, Mathis D, Benoist C, Davis MM. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell. 1989;58:1035-46.
10. Ashton-Rickardt P, van Kaer L, Schumacher TNM, Ploegh HL, Tonegawa S. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell. 1993;73:1041-9.
11. Nossal GJV. Negative selection of lymphocytes. Cell. 1994;76:229-39.
12. Sprent J, Kishimoto H. The thymus and negative selection. Immunol Rev. 2002 Jul;185(1):126-35.
13. Zinkernagel R. On observing and analyzing disease versus signals. Nat Immunol. 2007 Jan;8(1):8-10.
14. Burnet F. The clonal selection theory of acquired immunity. Nashville (TN): Vanderbilt University Press; 1958.
15. Miller JF. Immunological function of the thymus. Lancet. 1961 Sep 30;2(7205):748-9.
16. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987;49:273-80.
17. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989 Nov 30;342(6249):559-61.
18. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 1988 Jun 23;333(6175):742-6.
19. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science. 1990 Dec 21;250(4988):1720-3.
20. Berg LJ, Frank GD, Davis MM. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell. 1990 Mar 23;60(6):1043-53.
21. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994 Feb 25;76(4):651-63.
22. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gascoigne NR. T-cell-receptor affn-ity and thymocyte positive selection. Nature. 1996 Jun 13;381(6583):616-20.
23. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity. 2000 Dec;13(6):829-40.
24. Huseby ES, White J, Crawford F, Vass T, Becker D, Pi-nilla C, Marrack P, Kappler JW. How the T cell repertoire becomes peptide and MHC specific. Cell. 2005 Jul 29;122(2):247-60.
25. Blackman M, Yague J, Kubo R, Gay D, Coleclough C, Palmer E, Kappler J, Marrack P. The T cell repertoire may be biased in favor of MHC recognition. Cell. 1986 Nov 7;47(3):349-57.
26. Merkenschlager M, Graf D, Lovatt M, Bommhardt U, Zamoyska R, Fisher AG. How many thymocytes audition for selection? J Exp Med. 1997 Oct 6;186(7):1149-58.
27. Petrie HT, Livak F, Schatz DG, Strasser A, Crispe IN, Shortman K. Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymo-cytes. J Exp Med. 1993 Aug 1;178(2):615-22.
28. van Meerwijk JP, Marguerat S, Lees RK, Germain RN, Fowlkes BJ, MacDonald HR. Quantitative impact of thy-mic clonal deletion on the T cell repertoire. J Exp Med. 1997 Feb 3;185(3):377-83.
29. Huesmann M, Scott B, Kisielow P, von Boehmer H. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 1991 Aug 9;66(3):533-40.
30. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol. 2001;19:47-64.
31. Aschenbrenner K, D'Cruz LM, Vollmann EH, Hinterberg-er M, Emmerich J, Swee LK, Rolink A, Klein L. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol. 2007 Apr;8(4):351-8.
32. Koble C, Kyewski B. The thymic medulla: a unique mi-croenvironment for intercellular self-antigen transfer. J Exp Med. 2009 Jul 6;206(7):1505-13.
33. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 1994 Nov 3;372(6501):100-3.
34. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 2001 Apr;14(4):417-24.
35. Sykes M. Mechanisms of tolerance induced via mixed chimerism. Front Biosci. 2007;12:2922-34.
36. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science. 1990 Jun 15;248(4961):1342-8.
37. Laufer TM, Dekoning J, Markowitz JS, Lo D, Glimcher LH. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on the thymus cortex. Nature. 1996;383:81-5.
38. Robey E, Fowlkles BJ. Selective events in T cell development. Ann Rev Immunol. 1994;12:675-705.
39. Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev. 2003 Feb;3(2):147-58.
40. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003 Apr;4(4):330-6.
41. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science. 2003 Feb 14;299(5609):1057-61.
42. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Im-munologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-64.
43. Chess L, Jiang H. Resurrecting CD8+ suppressor T cells. Nat Immunol. 2004 May;5(5):469-71.
44. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythema-tosus patients. Immunity. 2010 Jan 29;32(1):129-40.
45. Thomson CW, Lee BP, Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol Res. 2006;35(1-2):163-78.
46. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, Jessberger R, Trinchieri G, Lira SA, Randolph GJ, Bromberg JS. Alloantigen-pre- senting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006 Jun;7(6):652-62.
47. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev. 2007 Aug;7(8):610-21.
48. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005 Feb 15;105(4):1815-22.
49. Brem-Exner BG, Sattler C, Hutchinson JA, Koehl GE, Kronenberg K, Farkas S, Inoue S, Blank C, Knechtle SJ, Schlitt HJ, Fandrich F, Geissler EK. Macrophages driven to a novel state of activation have anti-infammatory properties in mice. J Immunol. 2008 Jan 1;180(1):335-49.
50. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafni P, Zanovello P, Segal DM. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol. 2002 Jan 15;168(2):689-95.
51. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007 Feb;8(2):191-7.
52. Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev. 2010 Dec;10(12):849-59.
53. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005 Apr;6(4):345-52.
54. Le Douarin N, Corbel C, Bandeira A, Thomas-Vaslin V, Mo-digliani Y, Coutinho A, Salaun J. Evidence for a thymus-depen-dent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev. 1996;149:35-53:35-53.
55. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982 Dec 1;156(6):1577-86.
56. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfn in CD4+CD25+ T regulatory cells. Nat Immunol. 2003 Apr;4(4):337-42.
57. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol. 2002 Jan;3(1):33-41.
58. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008 Oct 10;322(5899):271-5.
59. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007 Jan 14.
60. Sakaguchi S, Miyara M, Costantino CM, Hafer DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev. 2010 Jul;10(7):490-500.
61. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev. 2008 Jul;8(7):523-32.
62. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamagu-chi T. Regulatory T cells: how do they suppress immune responses? Int Immunol. 2009 Oct;21(10):1105-11.
63. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009 May;30(5):636-45.
64. Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today. 1992 Apr;13(4):131-6.
65. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003 Dec 15;198(12):1875-86.
66. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004 May 17;199(10):1401-8.
67. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nus-senzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005 Dec;6(12):1219-27.
68. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'Shea J J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007 Mar;26(3):371-81.
69. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stock-inger B. TGFbeta in the context of an infammatory cy-tokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006 Feb;24(2):179-89.
70. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007 Aug 6;204(8):1765-74.
71. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-{beta} and retinoic acid dependent mechanism. J Exp Med. 2007 Aug 6;204(8):1757-64.
72. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kro-nenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007 Jul 13;317(5835):256-60.
73. Hori S. Developmental plasticity of Foxp3+ regulatory T cells. Curr Opin Immunol. 2010 Oct;22(5):575-82.
74. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005 Mar;22(3):329-41.
75. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 2009 May;30(5):626-35.
76. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity. 2009 May;30(5):616-25.
77. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 2007 Nov;27(5):786-800.
78. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimu-lation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of in-terleukin 2. Nat Immunol. 2005 Feb;6(2):152-62.
79. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosen-thal W, Bluestone JA. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009 Sep;10(9):1000-7.
80. Voo KS, Wang YH, Santori FR, Boggiano C, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ. Identifcation of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA. 2009 Mar 24;106(12):4793-8.
81. Duarte JH, Zelenay S, Bergman ML, Martins AC, Demen-geot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol. 2009 Apr;39(4):948-55.
82. Matsuoka K, Kim HT, McDonough S, Bascug G, War-shauer B, Koreth J, Cutler C, Ho VT, Alyea EP, Antin JH, Soiffer RJ, Ritz J. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic he-matopoietic stem cell transplantation. J Clin Invest. 2010 May 3;120(5):1479-93.
83. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polan-sky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfing E, Hamann A, Huehn J. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007 Feb;5(2):e38.
84. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007 Jun 1;178(11):6725-9.
85. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA. 2009 Feb 10;106(6):1903-8.
86. Merkenschlager M, von Boehmer H. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med. 2010 Jul 5;207(7):1347-50.
87. Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA meth-ylation. J Exp Med. 2007 Jul 9;204(7):1543-51.
88. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, Tur-bachova I, Hamann A, Olek S, Huehn J. DNA demethyla-tion in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol. 2007 Sep;37(9):2378-89.
89. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J. DNA methylation controls Foxp3 gene expression. Eur J Immunol. 2008 Jun;38(6):1654-63.
90. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010 Feb 11;463(7282):808-12.
91. Singer A, Adoro S, Park JH. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev. 2008 Oct;8(10):788-801.
92. van de Keere F, Tonegawa S. CD4 T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med. 1998;188:1875-82.
93. Olivares-Villagomez D, Wand Y, Lafaille JJ. Regulatory CD4+ T Cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med. 1998;188:1883-94.
94. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immu-nologic self-tolerance. J Immunol. 1999;162(9):5317-26.
95. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holen-beck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001;2(4):301-6.
96. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immuno-regulatory T cells. J Exp Med. 2001 Aug 20;194(4):427-38.
97. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002 Aug;3(8):756-63.
98. Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, Koni PA, Rudensky AY. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci USA. 2008 Aug 19;105(33):11903-8.
99. Bautista JL, Lio CW, Lathrop SK, Forbush K, Liang Y, Luo J, Rudensky AY, Hsieh CS. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol. 2009 Jun;10(6):610-7.
100. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007 Aug 6;204(8):1775-85.
101. DiPaolo RJ, Shevach EM. CD4+ T-cell development in a mouse expressing a transgenic TCR derived from a Treg. Eur J Immunol. 2009 Jan;39(1):234-40.
102. Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Seto-guchi K, Miyazaki J, Yamamoto K. Generation of CD4(+) CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol. 2002 May 1;168(9):4399-405.
103. Proietto AI, van Dommelen S, Zhou P, Rizzitelli A, D'Amico A, Steptoe RJ, Naik SH, Lahoud MH, Liu Y, Zheng P, Shortman K, Wu L. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci USA. 2008 Dec 16;105(50):19869-74.
104. Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, Hall VL, Willette-Brown J, Hurwitz AA, Leonard WJ, Durum SK. Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood. 2008 Oct 15;112(8):3283-92.
105. Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005 Aug 25;436(7054):1181-5.
106. Nazarov-Stoica C, Surls J, Bona C, Casares S, Brumeanu TD. CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message. J Immunol. 2009 Jan 1;182(1):102-10.
107. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregu-latory T cells that control autoimmune diabetes. Immunity. 2000 Apr;12(4):431-40.
108. Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol. 2006 Apr;7(4):401-10.
109. Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity. 2006 Aug;25(2):249-59.
110. Wong J, Obst R, Correia-Neves M, Losyev G, Mathis D, Benoist C. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J Immunol. 2007 Jun 1;178(11):7032-41.
111. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Ruden-sky AY. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity. 2004 Aug;21(2):267-77.
112. van Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med. 2004 Nov 15;200(10):1221-30.
113. Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a defciency in regulatory T cells. Proc Natl Acad Sci USA. 2005 Oct 11;102(41):14735-40.
114. Kyewski B, Derbinski J, Gotter J, Klein L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol. 2002 Jul;23(7):364-71.
115. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002 Nov 15;298(5597):1395-401.
116. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity. 2005 Aug;23(2):227-39.
117. Murphy DB, Lo D, Rath S, Brinster RL, Flavell RA, Slan-etz A, Janeway CA, Jr. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature. 1989 Apr 27;338(6218):765-8.
118. Rudensky AY, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA, Jr. On the complexity of self. Nature. 1991;353(6345):660-2.
119. Liu YJ. A unified theory of central tolerance in the thymus. Trends Immunol. 2006 May;27(5):215-21.
120. Le Borgne M, Ladi E, Dzhagalov I, Herzmark P, Liao YF, Chakraborty AK, Robey EA. The impact of negative selection on thymocyte migration in the medulla. Nat Immunol. 2009 Aug;10(8):823-30.
121. Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meer-wijk J P. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood. 2004 Jun 1;103(11):4216-21.
122. Graca L, Le Moine A, Lin CY, Fairchild PJ, Cobbold SP, Waldmann H. Donor-specific transplantation tolerance: The paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci USA. 2004 Jun 24;101:10122-26.
123. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol. 2002 Feb 1;168(3):1080-6.
124. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998 Dec;10(12):1969-80.
125. Thornton AM, Shevach EM. CD4+CD25+ immunoregula-tory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998 Jul 20;188(2):287-96.
126. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA. 2008 Jul 22;105(29):10113-8.
127. Shevach EM, Suri-Payer E, Amar AZ, Thornton AM. CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 1998;160:1212-8.
128. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vi-gnali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007 Nov 22;450(7169):566-9.
129. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol. 2000;164(1):183-90.
130. Wong J, Mathis D, Benoist C. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J Exp Med. 2007 Sep 3;204(9):2039-45.
131. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003 Feb 14;299(5609):1033-6.
132. White-Scharf ME, Banerjee P, Sachs DH, LeGuern C. Applications of gene therapy in transplantation. Gene Ther Mol Biol. 1997;1:333-44.
133. LeGuern C. Regulation of T Lymphocyte Functions by MHC Class II Self-Presentation. Trends Immunol. 2003 Dec;24(12):633-8.
134. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol. 2007 Nov;37 Suppl 1:S53-S60.
135. Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev. 2010 Mar;234(1):5-17.
136. Samy ET, Parker LA, Sharp CP, Tung KS. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med. 2005 Sep 19;202(6):771-81.
137. Tomura M, Honda T, Tanizaki H, Otsuka A, Egawa G, Tokura Y, Waldmann H, Hori S, Cyster JG, Watanabe T, Miyachi Y, Kanagawa O, Kabashima K. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest. 2010 Mar 1;120(3):883-93.
138. Graca L, Cobbold SP, Waldmann H. Identifcation of regulatory T cells in tolerated allografts. J Exp Med. 2002 Jun 17;195(12):1641-6.
139. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishma-nia major persistence and immunity. Nature. 2002 Dec 5;420(6915):502-7.
140. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L, Blazar BR, Serody JS. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood. 2005 Nov 1;106(9):3300-7.
141. Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med. 2005 Nov 21;202(10):1387-97.
142. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cy-tokine production by effector and regulatory T cells in in-famed skin. Immunity. 2009 Feb;30(2):277-88.
143. Hill JA, Benoist C, Mathis D. Treg cells: guardians for life. Nat Immunol. 2007 Feb;8(2):124-5.
144. McHugh RS, Shevach EM. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not suff-cient, for induction of organ-specific autoimmune disease. J Immunol. 2002 Jun 15;168(12):5979-83.
145. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Spar-wasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Litt-man DR, Lang RA. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity. 2002 Aug;17(2):211-20.
146. Lahl K, Sparwasser T. In vivo depletion of FoxP3(+) Tregs using the DEREG Mouse Model. Methods Mol Biol. 2011;707:157-72.
147. Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal infammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol. 2008 Apr 15;180(8):5163-6.
148. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, van Meerwijk JP. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med. 2008 Jan;14(1):88-92.
149. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 2001 Jun 4;193(11):1311-8.
150. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo ac tivated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002 May 15;99(10):3493-9.
151. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H. Infectious transplantation tolerance. Science. 1993;259:974-7.
152. Hori S, Haury M, Coutinho A, Demengeot J. Specific-ity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA. 2002;99(12):8213-8.
153. Suffa IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med. 2006 Mar 20;203(3):777-88.
154. O'Connell PJ, Li W, Wang Z, Specht SM, Logar AJ, Thomson AW. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol. 2002 Jan 1;168(1):143-54.
155. Raimondi G, Sumpter TL, Matta BM, Pillai M, Corbitt N, Vodovotz Y, Wang Z, Thomson AW. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol. 2010 Jan 15;184(2):624-36.
156. Thomson AW, Turnquist HR, Zahorchak AF, Raimondi G. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation. 2009 May 15;87(9 Suppl):S86-90.
157. LeGuern C, Akiyama Y, Tanaka K, Germana S, Iwamoto Y, Fernandez L, Houser S, Benichou G. Intracellular MHC class II controls regulatory tolerance to allogeneic transplants. J Immunol. 2010 Mar 1;184(5):2394-400.
158. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008 May;28(5):687-97.
159. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med. 2009 Mar 30;206(4):751-60.
160. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006 Jul 10;203(7):1693-700.
161. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006 Jul 10;203(7):1701-11.
162. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity. 2009 May;30(5):656-65.
163. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011 Jan 20;117(3):1061-70.